Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Acquisitions (2018 - 2023)

Orthofix Medical (OFIX) has disclosed Acquisitions for 5 consecutive years, with $29.4 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Acquisitions changed N/A year-over-year to $29.4 million, compared with a TTM value of $29.4 million through Dec 2023, changed N/A, and an annual FY2023 reading of $29.4 million, changed N/A over the prior year.
  • Acquisitions was $29.4 million for Q1 2023 at Orthofix Medical, up from $1.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $29.4 million in Q1 2023 and bottomed at $1.0 million in Q1 2021.
  • Average Acquisitions over 3 years is $16.1 million, with a median of $18.0 million recorded in 2020.
  • Peak annual rise in Acquisitions hit 94.44% in 2021, while the deepest fall reached 94.44% in 2021.
  • Year by year, Acquisitions stood at $18.0 million in 2020, then tumbled by 94.44% to $1.0 million in 2021, then skyrocketed by 2841.9% to $29.4 million in 2023.
  • Business Quant data shows Acquisitions for OFIX at $29.4 million in Q1 2023, $1.0 million in Q1 2021, and $18.0 million in Q1 2020.